Back
Day Range
$5.11
$5.48
52-Week Range
$1.29
$7.18
Volume
2,008,021
50D / 200D Avg
$5.73
/
$3.77
Prev Close
$5.11
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -4.7 | 0.4 |
| P/B | 2.2 | 2.9 |
| ROE % | -50.8 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$16.00
+198.0%
Forward EPS
-$0.93
Est. Revenue
3.2 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$0.79
$0.79 – $0.79
|
480 M | 4 |
| FY2028 |
$0.14
-$0.49 – $1.03
|
260 M | 6 |
| FY2027 |
-$0.59
-$0.84 – -$0.37
|
63 M | 7 |
Key Takeaways
Debt/Equity of 0.10 — conservative balance sheet
Negative free cash flow of -118.02M
PEG of 0.12 suggests growth is underpriced
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-50.84%
ROIC-35.88%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.10
Current Ratio10.37
Interest Coverage0.00
Valuation
P/E Ratio
-4.65
P/B Ratio2.19
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -138.20M |
| ROE | -50.84% | ROA | -39.48% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -118.02M |
| ROIC | -35.88% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.10 | Current Ratio | 10.37 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -4.65 | P/B Ratio | 2.19 |
| P/S Ratio | N/A | PEG Ratio | 0.12 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 642.23M | Enterprise Value | 621.70M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -138.20M | -134.24M | -141.95M | -130.32M | -63.41M |
| EPS (Diluted) | -1.01 | -1.77 | -2.60 | -3.34 | -3.70 |
| Gross Profit | -3.45M | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -154.07M | -143.72M | -145.60M | -130.71M | -63.47M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 350.07M | 297.67M | 285.10M | 287.04M | 355.95M |
| Total Liabilities | 56.97M | 47.12M | 53.90M | 55.13M | 11.67M |
| Shareholders' Equity | 293.11M | 250.56M | 231.19M | 231.91M | 344.28M |
| Total Debt | 28.97M | 31.36M | 32.86M | 34.59M | 0.0 |
| Cash & Equivalents | 49.50M | 225.11M | 140.02M | 74.84M | 268.57M |
| Current Assets | 316.46M | 263.86M | 248.10M | 247.69M | 354.01M |
| Current Liabilities | 30.51M | 17.93M | 22.36M | 21.74M | 10.62M |